| Behavioral and Brain Functions | |
| Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden | |
| Elise Gieling2  Welmoed Wehkamp3  Remco Willigenburg3  Rebecca E Nordquist2  Niels-Christian Ganderup1  Franz Josef van der Staay2  | |
| [1] Ellegaard Göttingen Minipigs A/S, Soroe Landevej 302, Dalmose, DK-4261, Denmark | |
| [2] Rudolf Magnus Institute of Neuroscience, Utrecht University, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands | |
| [3] HAS Den Bosch, University of Applied Sciences, Postbus 90108, ‘s-Hertogenbosch, The Netherlands | |
| 关键词: Biperiden; Spatial learning task; Holeboard task; Animal model; Reference memory; Working memory; | |
| Others : 793707 DOI : 10.1186/1744-9081-9-4 |
|
| received in 2012-07-03, accepted in 2012-12-23, 发布年份 2013 | |
PDF
|
|
【 摘 要 】
Background
The pig is emerging as a model species that bridges the gap between rodents and humans in research. In particular, the miniature pig (referred to hereafter as the minipig) is increasingly being used as non-rodent species in pharmacological and toxicological studies. However, there is as yet a lack of validated behavioral tests for pigs, although there is evidence that the spatial holeboard task can be used to assess the working and reference memory of pigs. In the present study, we compared the learning performance of commercial pigs and Göttingen minipigs in a holeboard task.
Methods
Biperiden, a muscarinic M1 receptor blocker, is used to induce impairments in cognitive function in animal research. The two groups of pigs were treated orally with increasing doses of biperiden (0.05 – 20 mg.kg-1) after they had reached asymptotic performance in the holeboard task.
Results
Both the conventional pigs and the Göttingen minipigs learned the holeboard task, reaching nearly errorless asymptotic working and reference memory performance within approximately 100 acquisition trials. Biperiden treatment affected reference, but not working, memory, increasing trial duration and the latency to first hole visit at doses ≥ 5 mg.kg-1.
Conclusion
Both pig breeds learned the holeboard task and had a comparable performance. Biperiden had only a minor effect on holeboard performance overall, and mainly on reference memory performance. The effectiveness needs to be evaluated further before definitive conclusions can be drawn about the ability of this potential cognition impairer in pigs.
【 授权许可】
2013 Gieling et al.; licensee BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20140705054647219.pdf | 877KB | ||
| Figure 3. | 223KB | Image | |
| Figure 2. | 36KB | Image | |
| Figure 1. | 159KB | Image |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
【 参考文献 】
- [1]Swindle MM, Makin A, Herron AJ, Clubb FJJ, Frazier KS: Swine as models in biomedical research and toxicology testing. Vet Pathol 2012, 49(2):344-356.
- [2]Bollen P, Ritskes-Hoitinga M: The welfare of pigs and minipigs. In The welfare of laboratory animals. Edited by Marchant-Forde JN. Dordrecht: Springer; 2007:275-289.
- [3]Walters EM, Agca Y, Ganjam V, Evans T: Animal models got you puzzled?: think pig. Ann NY Acad Sci 2011, 1245:63-64.
- [4]van der Laan JW, Brightwell J, McAnulty P, Ratky J, Stark C: Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products. J Pharmacol Toxicol Methods 2010, 62:184-195.
- [5]Gieling ET, Schuurman T, Nordquist RE, van der Staay FJ: The pig as a model animal for studying cognition and neurobehavioral disorders. In Molecular and functional models in neuropsychiatry. Edited by Hagan J. Berlin, Heidelberg: Springer-Verlag; 2010:359-383.
- [6]Gieling ET, Nordquist RE, van der Staay FJ: Assessing learning and memory in pigs. Anim Cogn 2011, 14(2):151-173.
- [7]Kornum BR, Knudsen GM: Cognitive testing of pigs (sus scrofa) in translational biobehavioral research. Neurosci Biobehav Rev 2011, 35:437-451.
- [8]Arts JWM, van der Staay FJ, Ekkel ED: Working and reference memory of pigs in the spatial holeboard discrimination task. Behav Brain Res 2009, 205(1):303-306.
- [9]Gieling ET, Park SY, Nordquist RE, van der Staay FJ: Performance of low- and normal birth weight piglets in a spatial holeboard discrimination task. Pediatr Res 2012, 71(1):71-76.
- [10]van der Staay FJ, Gieling ET, Espitia Pinzón N, Nordquist RE, Ohl F: The appetitively motivated “cognitive” holeboard: A family of complex spatial discrimination tasks for assessing learning and memory. Neurosci Biobehav Rev 2012, 36(1):379-403.
- [11]Olton DS, Becker JT, Handelmann GE: Hippocampus, space, and memory. Behav Brain Sci 1979, 2:313-365.
- [12]Bannerman DM, Sprengel R: Remembering the subtle differences. Science 2007, 317:50-51.
- [13]Dudchenko PA: An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 2004, 28:699-709.
- [14]Manton JC: Preliminary investigation of behaviour, learning and memory assessments in the juvenile Göttingen minipig [Abstract]. Reprod Toxicol 2010, 30:241.
- [15]Deiana S, Platt B, Riedel G: The cholinergic system and spatial learning. Behav Brain Res 2011, 221:389-411.
- [16]de Leon : Paying attention to pharmacokinetic and pharmacodynamic mechanisms to progress in the area of anticholinergic use in geriatric patients. Curr Drug Metab 2011, 12:635-646.
- [17]Klinkenberg I, Blokland A: The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci Biobehav Rev 2010, 34(8):1307-1350.
- [18]Bouger PCM, van der Staay FJ: Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: Animal models for impaired spatial orientation performance. Eur Neuropsychopharmacol 2005, 15(3):331-346.
- [19]Klinkenberg I, Blokland A: A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology 2011, 215(3):549-566.
- [20]Grimaldi R, Perucca E, Ruberto G, Gelmi C, Trimarchi F, Hollmann M, Crema A: Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects. Eur J Clin Pharmacol 1986, 29:735-737.
- [21]Hanna C: Toxicologic studies on biperiden (Akineton) (1-bicycloheptenyl-1-phenyl-3-piperidinopropanol-1). Toxicol Appl Pharmacol 1960, 2(4):379-391.
- [22]DailyMed database. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1093#nlm34084-4 webcite
- [23]Wezenberg E, Verkes RJ, Sabbe BGC, Ruigt GSF, Hulstijn W: Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. Psychopharmacology 2005, 181:582-594.
- [24]Silver H, Geraisy N: Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients. A double-blind cross-over study. Br J Psychiatry 1995, 166:241-243.
- [25]Liang C, Ho P, Shen L, Lee W, Yang F, Chiang K: Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: A randomized, double-blind, crossover study. Schizophr Res 2010, 119:138-144.
- [26]Roldán G, Bolaños-Badillo E, González-Sánchez H, Quirarte GL, Prado-Alcalá RA: Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neurosci Lett 1997, 230(2):93-96.
- [27]Schwabe L, Joëls M, Roozendaal B, Wolf OT, Oitzl MS: Stress effects on memory: An update and integration. Neurosci Biobehav Rev 2012, 36(7):1740-1749.
- [28]Ellegaard L, Cunningham A, Edwards S, Grand N, Nevalainen T, Prescott M, Schuurman T: Welfare of the minipig with special reference to use in regulatory toxicology studies. J Pharmacol Toxicol Methods 2010, 62(3):167-183.
- [29]Gerretsen P, Pollock BG: Drugs with anticholinergic properties: A current perspective on use and safety. J Med Econ 2011, 10(5):751-765.
- [30]Downes N: Juvenile toxicity: Are we asking the right questions? Toxicol Pathol 2012, 00:1-8.
- [31]van der Staay FJ, Rutten K, Erb C, Blokland A: Effects of the cognition impairer MK-801 on learning and memory in mice and rats. Behav Brain Res 2011, 220(1):215-229.
- [32]Liu W: Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats. Pharmacol Biochem Behav 1996, 54(2):425-430.
- [33]Yokogawa K, Nakashima EMI, Ichimura F: Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats. Drug Metab Dispos 1990, 18(2):258-263.
- [34]Kimura Y, Ohue M, Kitaura T, Kihira K: Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: Differences in binding properties to the brain muscarinic receptor. Brain Res 1999, 834:6-12.
PDF